Prevalent human coxsackie B-5 virus infects porcine islet cells primarily using the coxsackie-adenovirus receptor

Xenotransplantation

Volumn 11, Issue 6, 2004, Pages 536-546

  Myers, Suzanne E ^a   Brewer, Laurie ^b   Shaw, Daniel P ^a   Greene, Wallace H ^c   Love, Brenda C ^a   Hering, Bernhard ^d   Spiller, O Brad ^e   Njenga, M Kariuki ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Coxsackie B 5 virus; Porcine islet cells; Virus receptor; Xenozoonosis

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; DECAY ACCELERATING FACTOR ANTIBODY; MEMBRANE COFACTOR PROTEIN; MEMBRANE COFACTOR PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS B5; CYTOLYSIS; DIABETES MELLITUS; ENCEPHALOMYOCARDITIS VIRUS; NONHUMAN; PANCREAS ISLET CELL; PICORNAVIRUS; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; DIABETES MELLITUS, EXPERIMENTAL; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED C57BL; NEUTRALIZATION TESTS; RECEPTORS, VIRUS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 7044253643     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2004.00183.x     Document Type: Article

References (57)

1. MACKENZIE DA, HULLETT DA, SOLLINGER HW. Xenogeneic transplantation of porcine islets: an overview. Transplantation 2003; 76: 887.
2. CUNNINGHAM DA, HERRING C, FERNANDEZ-SUAREZ XM et al. Analysis of patients treated with living pig tissue for evidence of infection by porcine endogenous retroviruses. Trends Cardiovasc Med 2001; 11: 190.
3. DINSMORE JH, MANHART C, RAINERI R, JACOBY DB, MOORE A. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 2000; 70: 1382.
4. HENEINE W, TIBELL A, SWITZER WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352: 695.
5. PITKIN Z, MULLON C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 1999; 23: 829.
6. OLDMIXON BA, WOOD JC, ERICSSON TA et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002; 76: 3045.
7. NIEBERT M, TONJES RR. Analyses of prevalence and polymorphisms of six replication-competent and chromosomally assigned porcine endogenous retroviruses in individual pigs and pig subspecies. Virology 2003; 313: 427.
8. NIEBERT M, TONJES RR. Molecular cloning and functional characterization of infectious PERV and development of diagnostic tests. Curr Top Microbiol Immunol 2003; 278: 217.
9. SACHS DH, LEIGHT G, CONE J et al. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976; 22: 559.
10. QUINN G, WOOD J, SULING K et al. Genotyping of porcine endogenous retroviruses from a family of miniature swine. J Virol 2004; 78: 314.
11. SOLA R, DIAZ JM, GUIRADO L et al. Significance of cytomegalovirus infection in renal transplantation. Transplant Proc 2003; 35: 1753.
12. PAUL PS, HALBUR P, JANKE B et al. Exogenous porcine viruses. Curr Top Microbiol Immunol 2003; 278: 125.
13. BREWER L, BROWN C, MURTAUGH MP, NJENGA MK. Transmission of porcine encephalomyocarditis virus (EMCV) to mice by transplanting EMCV-infected pig tissues. Xenotransplantation 2003; 10: 569.
14. BREWER LA, LWAMBA HC, MURTAUGH MP et al. Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells. J Virol 2001; 75: 11621.
15. LARUE R, MYERS S, BREWER L et al. A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques. J Virol 2003; 77: 9136.
16. BREWER L, LARUE R, HERING BJ, BROWN C, NJENGA MK. Transplanting encephaolmyocarditis virus-infected porcine islet cells reverses diabetes in recipient mice but also transmits the virus. Xenotransplantation 2004; 11: 160.
17. PALLANSCH M, Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: KNIPE DM, HOWLEY PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins, 2001.
18. MODLIN JF. Coxsackieviruses, echoviruses, and newer enteroviruses. In: MANDELL G, DOUGLAS RJ, JE B, eds. Principles and Practices of Infectious Diseases. New York: Churchill Livingstone, 1990.
19. MORENS D, PALLANSCH M, MOORE M. Polioviruses and other enteroviruses. In: BELSHE RB, ed. Textbook of Human Virology. St Louis, MO: Mosby Year Book, 1991.
20. BABOONIAN C, DAVIES MJ, BOOTH JC, MCKENNA WJ. Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 1997; 223: 31.
21. BARRETT-CONNER E. Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis 1985; 7: 207.
22. FOHLMAN J, FRIMAN G. Is juvenile diabetes a viral disease? Ann Med 1993; 25: 569.
23. KAPLAN MH, KLEIN SW, MCPHEE J, HARPER RG. GROUP B Coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5: 1019.
24. WOODRUFF JF. Viral myocarditis. A review. Am J Pathol 1980; 101: 425.
25. MARTINO T, LIU P, PETRIC M, SOLE M. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. In: ROTBART H, ed. Human Enterovirus Infections. Washington, DC: ASM Press, 1995.
26. RAMSINGH AI, CHAPMAN N, TRACY S. Coxsackieviruses and diabetes. Bioessays 1997; 19: 793.
27. YOON JW, AUSTIN M, ONODERA T, NOTKINS AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173.
28. YOON JW, LONDON WT, CURFMAN BL, BROWN RL, NOTKINS AL. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986; 35: 712.
29. ROIVAINEN M, RASILAINEN S, YLIPAASTO P et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000; 85: 432.
30. CHEHADEH W, KERR-CONTE J, PATTOU F et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000; 74: 10153.
31. MONLUX VS, MCKERCHER PD, GRAVES JH. Brain and spinal cord lesions in pigs inoculated with swine vesicular disease (UKG strain) virus and coxsackievirus B5. Am J Vet Res 1975; 36: 1745.
32. KNOWLES NJ, BUCKLEY LS, PEREIRA HG. Classification of porcine enteroviruses by antigenic analysis and cytopathic effects in tissue culture: description of 3 new serotypes. Arch Virol 1979; 62: 201.
33. ZHANG G, WILSDEN G, KNOWLES NJ, MCCAULEY JW. Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. J Gen Virol 1993; 74: 845.
34. ROIVAINEN M, YLIPAASTO P, USTINOV J, HOVI T, OTONKOSKI T. Screening enteroviruses for beta-cell tropism using foetal porcine beta-cells. J Gen Virol 2001; 82: 1909.
35. SHAFREN DR, BATES RC, AGREZ MV et al. B5 use decay-accelerating factor as a receptor for cell attachment. J Virol 1995; 69: 3873.
36. MARTINO TA, PETRIC M, WEINGARTL H et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000; 271: 99.
37. GAGGAR A, SHAYAKHMETOV DM, LIEBER A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408.
38. BENNET W, BJORKLAND A, SUNDBERG B et al. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs. Transplantation 2001; 72: 312.
39. BRANDHORST H, BRANDHORST D, HERING BJ, BRETZEL RG. Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion. Transplantation 1999; 68: 355.
40. NJENGA MK, ASAKURA K, HUNTER SF et al. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol 1997; 71: 8592.
41. SPILLER OB, GOODFELLOW IG, EVANS DJ et al. viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF. J Gen Virol 2002; 83: 45.
42. HONIG EI, MELNICK JL, ISACSON P et al. An endemiological study of enteric virus infections: poliomyelitis, coxsackie, and orphan (ECHO) viruses isolated from normal children in two socioeconomic groups. J Exp Med 1956; 103: 247.
43. HU H, DONG D, TANG E, ZHANG M, CAO Y. Antigenic analysis of coxsackievirus B3 with monoclonal antibodies. Jpn J Med Sci Biol 1993; 46: 87.
44. PEIGUE-LAFEUILLE H, BAILLY JL, AYMARD M, FUCHS F. Use of non-neutralizing monoclonal antibodies in an ELISA for intratypic differentiation of 28 echovirus type 25 clinical isolates. J Virol Methods 1992; 36: 91.
45. HE Y, CHIPMAN PR, HOWITT J et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 2001; 8: 874.
46. HE Y, LIN F, CHIPMAN PR et al. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc Natl Acad Sci U S A 2002; 99: 10325.
47. STUART AD, McKEE TA, WILLIAMS PA et al. Determination of the structure of a decay-accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. J Virol 2002; 76: 7694.
48. ROSSMANN MG, HE Y, KUHN RJ. Picornavirus-receptor interactions. Trends Microbiol 2002; 10: 324.
49. NEWCOMBE NG, ANDERSSON P, JOHANSSON ES et al. Cellular receptor interactions of C-cluster human group A coxsackieviruses. J Gen Virol 2003; 84: 3041.
50. SHAFREN DR, WILLIAMS DT, BARRY RD. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol 1997; 71: 9844.
51. BERGELSON JM, ST JOHN NF, KAWAGUCHI S et al. The I domain is essential for echovirus 1 interaction with VLA-2. Cell Adhes Commun 1994; 2: 455.
52. BERGELSON JM, MODLIN JF, WIELAND-ALTER W et al. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 1997; 175: 697.
53. BERGELSON JM, CUNNINGHAM JA, DROGUETT G et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320.
54. FRISK G, ELFSTROM T, DIDERHOLM H. The replication of certain Coxsackie B virus strains in CHO cells. J Virol Methods 2001; 98: 161.
55. ZAUTNER AE, KORNER U, HENKE A, BADORFF C, SCHMIDTKE M. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 2003; 77: 10071.
56. ALEXANDER DA, DIMOCK K. Sialic acid functions in enterovirus 70 binding and infection. J Virol 2002; 76: 11265.
57. DE VERDUGO UR, SELINKA HC, HUBER M et al. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol 1995; 69: 6751.